West Midlands regional quality control scheme for haematology I. D. 0. FREW, T. W. ROOME, AND B. ASHMAN From Good Hope Hospital, Sutton Coldfield, Warwickshire SUMMARY A regional quality control scheme is described together with details of the organisation, preparation of material, and an evaluation of the results.
To meet a recognised need a scheme for interlaboratory quality control was devised in May 1974 for six laboratories in the Birmingham area. The number of participating laboratories has since increased to 30, which constitutes the majority of haematology laboratories in the West Midlands Region. Trials are held fortnightly and statistical data are returned within 24 hours of testing the issued samples. The success of the scheme has been mainly due to the rapid return ofresults-and statistical data. The scheme has also been shown to be complementary to the DHSS/BCSH Proficiency Assessment Service (Ward and Lewis, 1975 ).
Participants and methods
There is a diversity of participating laboratories and therefore a variety of instrumentation and methodology (Tables 1, 2) . Each laboratory has a recognition code but the identity of each laboratory is known to all participants and therefore there is no anonymity within the scheme.
PREPARATION OF SAMPLES
Because of problems of stability two separate samples are prepared. Sample 1 is for haemoglobin (Hb), red cell count (RBC), mean cell volume (MCV), and white cell count (WBC). Sample 2 is for platelets. All samples are negative for hepatitis associated antigen activity.
Sample 1
Freshly collected blood which is unsuitable for transfusion is provided by the West Midlands Blood Transfusion Service. Occasionally patient venesection blood is used as the base for the trial sample. Gentamicin as a bacteriostatic agent is added to about 200 ml of blood in citrate phosphate dextrose Received for publication 15 December 1976 to give a minimum concentration of 10 ,ug/ml of blood. A stable WBC count is prepared by a modification of a method for stable RBC suspensions (Lewis and Burgess, 1966) as follows: 1-5 ml of the gentamicin-treated blood is washed three times in sterile physiological saline; 20 ml of freshly prepared 0-25 % (v/v) glutaraldehyde in sterile phosphate buffer pH 7-4 is slowly added to the washed RBC deposit, with gentle shaking; this is allowed to stand at room temperature for 90 minutes, then centrifuged, and the supernatant discarded; 2 ml of distilled water is added to the deposit and this is vortexmixed for two minutes; the volume is then made up to 20 ml with distilled water, centrifuged, and the supernatant discarded.
This procedure is repeated three times and then once more using physiological saline instead of distilled water. Some of the gentamicin-treated blood is added to the fixed red cell deposit; these are vortexmixed for two minutes; a proportion (dependent on the level of WBC required) is then added to the bulk gentamicin-treated blood, mixed by inversion, and stored at 4°C for at least 24 hours before use.
Sample 2 A sterile stock solution of ethylene-diamine-tetraacetic acid dipotassium salt is prepared and, with aseptic precautions, 0X2 ml is taken for each 1 ml of blood required for the trial. Gentamicin is added to give a final minimum concentration of 10 fig/ml. The required volume of blood, freshly drawn from volunteer donors, is then added and mixed by inversion. This sample is prepared on the day of issue of the trial.
ISSUE OF SAMPLES
On the day of issue both samples are mixed for a minimum of 30 minutes. Then, using an automatic pipette (Macroset), sample 1 is aliquoted into 4-ml volumes and sample 2 into 1-ml volumes (except for 641 
REPORTS AND RECORDS
Each laboratory is issued with a record sheet with every trial, which they keep as a permanent record of their trial result. As the results are telephoned in they are recorded on an input data sheet, which acts as a permanent record of all the trial results for the issuing laboratory. The calculator programme produces the mean, standard deviation, and coefficient of variation from all the results returned. Table 4 shows an example. Variance index (based on the mean of the three results) is calculated for each measurement from each laboratory (Table 5 ) and also presented in histogram form (Table 6 ). The calculator print-outs are then photocopied and the photocopies sent by first-class mail to all laboratories whether they returned results or not.
Discussion
The Prangnell and Johnson (1976) showed that the stated using commercial reference controls as standards and value for haemoglobin for a commercial reference not checking against a cyanmethaemoglobin control differed by 0 5 g/dl from the reference standards approved by the ISCH. Platelet count results varied greatly. On analysis by method they showed consistent patterns within the visual and the centrifugation method groups but the sedimentation method appeared erratic. These impressions may be invalid owing to the small numbers of laboratories in each method group. There was, however, disparity in the mean values from each group, and an investigation into methodology was reported by Ashman (1976) .
Comparisons between results from our scheme and the DHSS/BCSH Proficiency Assessment Service show that they closely agree. Difficulties have arisen in trying to assess the results cumulatively, mainly owing to lack of computer time. Trials of measuring vitamin B12 and folate concentrations and prothrombin times and activated partial thromboplastin times have been held, but as yet we have insufficient data on which to comment.
Conclusion
A quality control scheme for haematology of the type described offers a more immediate form of interlaboratory control for a reasonably large group of laboratories. A regional grouping, as in this scheme, provides sufficient data to be statistically viable and yet is small enough to nullify most problems caused by delay in sending specimens and receiving reports. 
